Insider Transactions in Q4 2024 at Protagonist Therapeutics, Inc (PTGX)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 27
2024
|
Arturo Md Molina Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
26,000
-21.67%
|
$1,144,000
$44.67 P/Share
|
Nov 27
2024
|
Arturo Md Molina Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,000
+17.72%
|
$208,000
$8.04 P/Share
|
Nov 26
2024
|
Arturo Md Molina Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,529
-10.64%
|
$248,805
$45.6 P/Share
|
Nov 26
2024
|
Arturo Md Molina Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,529
+9.62%
|
$44,232
$8.04 P/Share
|
Nov 26
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Open market or private sale
|
Direct |
21,480
-5.0%
|
$988,080
$46.25 P/Share
|
Nov 26
2024
|
Suneel Gupta Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,450
+4.83%
|
$365,400
$12.17 P/Share
|
Nov 26
2024
|
Suneel Gupta Chief Development Officer |
SELL
Open market or private sale
|
Direct |
19,191
-6.71%
|
$863,595
$45.5 P/Share
|
Nov 25
2024
|
Dinesh V Ph D Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,727
+0.4%
|
$36,267
$21.58 P/Share
|
Nov 25
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Bona fide gift
|
Direct |
7,000
-1.61%
|
-
|
Nov 25
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Open market or private sale
|
Direct |
78,520
-15.28%
|
$3,611,920
$46.96 P/Share
|
Nov 25
2024
|
Suneel Gupta Chief Development Officer |
SELL
Open market or private sale
|
Direct |
103,437
-28.76%
|
$4,758,102
$46.04 P/Share
|
Nov 25
2024
|
Suneel Gupta Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
175,000
+16.53%
|
$1,225,000
$7.73 P/Share
|
Nov 19
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Bona fide gift
|
Direct |
1,000
-0.19%
|
-
|
Nov 15
2024
|
Arturo Md Molina Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,906
-3.94%
|
$76,240
$40.98 P/Share
|